Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Completed × Advanced Solid Malignancy, × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1194 Breast Neoplasms 619 Carcinoma, Non-Small-Cell Lung 477 Lymphoma 394 Neoplasm Metastasis 390 Leukemia, Myeloid, Acute 381 Melanoma 355 Prostatic Neoplasms 335 Multiple Myeloma 327 Lymphoma, Non-Hodgkin 315 Ovarian Neoplasms 308 Pancreatic Neoplasms 294 Colorectal Neoplasms 294 Precursor Cell Lymphoblastic Leukemia-Lymphoma 288 Leukemia, Lymphocytic, Chronic, B-Cell 286 Leukemia 264 Lung Neoplasms 246 Unspecified Adult Solid Tumor, Protocol Specific 244 Glioblastoma 238 Recurrence 228 Lymphoma, Follicular 218 Brain Neoplasms 213 Lymphoma, Large B-Cell, Diffuse 212 Lymphoma, Mantle-Cell 185 Carcinoma, Renal Cell 171 Head and Neck Neoplasms 168 Hodgkin Disease 166 Myelodysplastic Syndromes 162 Stomach Neoplasms 155 Glioma 155

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01895946 2016-05-25

OAK

AstraZeneca

Phase 1 Completed

33 enrolled 14 charts

Advanced Solid Malignancy,

Data powered by HemOnc (CC BY 4.0) Colophon ⚡